Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Business
Anna Wise

Sales in weight-loss drug Mounjaro double amid surging market appetite

Mounjaro - (AFP/Getty)

Pharmaceutical firm Eli Lilly has reported a doubling in global sales for its diabetes and weight loss injection Mounjaro, fuelled by surging market appetite.

The drugmaker highlighted that its obesity treatments, Mounjaro and Zepbound, are spearheading a broader surge in company revenues.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.